These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22609162)

  • 1. Serum biomarker in neurofibromatosis type 1.
    Yoshida Y; Furumura M; Tahira M; Horie T; Yamamoto O
    J Dermatol Sci; 2012 Aug; 67(2):155-8. PubMed ID: 22609162
    [No Abstract]   [Full Text] [Related]  

  • 2. Local mast cell histamine and plasma histamine levels in neurofibromatosis type 1.
    Yoshida Y; Adachi K; Yamamoto O
    Acta Derm Venereol; 2010 Nov; 90(6):637-9. PubMed ID: 21057752
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of UVB light on serum concentrations of 5-S-cysteinyldopa.
    Tegner E; Agrup G; Rosengren E
    Acta Derm Venereol; 1983; 63(2):149-52. PubMed ID: 6189331
    [No Abstract]   [Full Text] [Related]  

  • 4. [Qualitative and quantitative data on melanocytes in neurofibromatosis (author's transl)].
    Terayama I
    Nihon Hifuka Gakkai Zasshi; 1975 Jun; 85(7):395-403. PubMed ID: 810608
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased cysteinyldopa plasma levels hint to melanocyte as stress sensor in psoriasis.
    Panzella L; Wakamatsu K; Monfrecola G; Ito S; Ayala F; Napolitano A
    Exp Dermatol; 2011 Mar; 20(3):288-90. PubMed ID: 21323749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
    De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
    Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vimentin antibodies and neuron-specific enolase in children with neurofibromatosis type-1.
    Kotaska K; Petrak B; Kukacka J; Kraus J; Prusa R
    Neuro Endocrinol Lett; 2007 Dec; 28(6):761-4. PubMed ID: 18063947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C; Rorsman H; Rosengren E; Tegner E
    Acta Derm Venereol; 1981; 61(3):251-5. PubMed ID: 6167110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The many faces of neurofibromatosis.
    Moore BC; Luce J
    Ariz Med; 1982 Feb; 39(2):99-102. PubMed ID: 6803740
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of skin pigmentation in the diagnosis of scoliosis in neurofibromatosis (Recklinghausen's disease)].
    Abal'masova EA; Buniatov RN
    Vestn Dermatol Venerol; 1979 Oct; (10):52-5. PubMed ID: 116433
    [No Abstract]   [Full Text] [Related]  

  • 11. Lisch spots in neurofibromatosis type 1.
    Saxena RC; Saxena S
    Indian J Ophthalmol; 1991; 39(4):179-80. PubMed ID: 1810882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy in neurofibromatosis.
    Hope DG; Mulvihill JJ
    Adv Neurol; 1981; 29():33-56. PubMed ID: 6798842
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum neuronal growth factor levels in von Recklinghausen's neurofibromatosis.
    Riopelle RJ; Riccardi VM; Faulkner S; Martin MC
    Ann Neurol; 1984 Jul; 16(1):54-9. PubMed ID: 6431898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Trp53 rescues the male fertility defects of Kit(W-v) mice but has no effect on the survival of melanocytes and mast cells.
    Jordan SA; Speed RM; Bernex F; Jackson IJ
    Dev Biol; 1999 Nov; 215(1):78-90. PubMed ID: 10525351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Type 1 neurofibromatosis: the experience of a hospital in Porto, Portugal].
    Madalena C; Pereira SA; Rosário C; Santos M; Barbot C
    Rev Neurol; 2001 Oct 16-31; 33(8):794-5. PubMed ID: 11784975
    [No Abstract]   [Full Text] [Related]  

  • 16. Central neurofibromatosis with bilateral acoustic neuroma.
    Eldridge R
    Adv Neurol; 1981; 29():57-65. PubMed ID: 6798843
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurofibromatosis: review of the literature.
    Stokes RW
    J Am Osteopath Assoc; 1986 Jan; 86(1):49-52. PubMed ID: 3081471
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ultrastructure of neurofibromatosis].
    Weber K; Braun-Falco O
    Hautarzt; 1972 Mar; 23(3):116-22. PubMed ID: 4623755
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neurofibromatosis type I--the pediatric endocrinologist's point of view].
    Januś D; Wójcik M; Kalicka-Kasperczyk A; Roztoczyńska D; Wojtyś J; Tyrawa K; Dolezal-Ołtarzewska K; Wcisło B; Was M; Starzyk J
    Przegl Lek; 2010; 67(11):1155-9. PubMed ID: 21442968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1.
    Mashour GA; Driever PH; Hartmann M; Drissel SN; Zhang T; Scharf B; Felderhoff-Müser U; Sakuma S; Friedrich RE; Martuza RL; Mautner VF; Kurtz A
    Clin Cancer Res; 2004 Sep; 10(17):5677-83. PubMed ID: 15355893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.